Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group. - Wikidata - awgldk - TriplyDB

Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.

Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.

http://www.wikidata.org/entity/Q35430146

about

Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging Strategies Effect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004.Survival Impact of Early Post-Transplant Toxicities in Pediatric and Adolescent Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Malignant and Nonmalignant Diseases: Recognizing Risks and Optimizing Outcomes Inclusion of Adolescents and Young Adults in Cancer Clinical Trials.Enhanced generation of cord blood hematopoietic stem and progenitor cells by culture with StemRegenin1 and Delta1(Ext-IgG.).The Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT) Cohort Study: a population-based cohort of young Canadians with cancer.Medication adherence decision-making among adolescents and young adults with cancer Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML).Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity.Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials.A critical review of which children with acute myeloid leukaemia need stem cell procedures.Association between body mass index at diagnosis and pediatric leukemia mortality and relapse: a systematic review and meta-analysis.Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis.Comparison of survival of adolescents and young adults with hematologic malignancies in Osaka, Japan.Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.A prospective, observational cohort study comparing cancer clinical trial availability and enrollment between early adolescents/young adults and children.Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia.Treatment-related mortality in newly diagnosed pediatric cancer: a population-based analysis.Acute myelogenous leukemia in adolescents and young adults.Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data.

P2860

Q28086955-B527A801-9F26-494E-8C6D-E15214E4BCA0 Q33573539-5068C296-4747-4AB5-BE58-F5222726EA19 Q33870341-88C04DB2-F5E0-48B0-BBA0-4C9C0913218A Q33922505-2725C691-C8FB-4114-B572-77AFAE17038F Q34315848-D1A92DA7-A676-44AC-A4C3-703C9383F204 Q34491288-068F138E-94A9-4641-A794-76232D87BD8E Q36446637-EF81D637-468A-4F0B-B4C6-AC349A588AC4 Q36739522-C5408CDF-7B37-4FDD-B9E6-1708E7B69159 Q37295115-005D505A-9DAD-47AF-977E-AED60A3E92FE Q37324869-215531F6-C01F-4694-B167-EDDAD61A774C Q38205864-7600E65F-AE40-48D3-A19D-C80A91DEDCC7 Q38603452-F3322B4F-BB89-449B-84C9-46E7EF967E0D Q38769534-DBCA4568-3D8A-4500-B285-9B1272A0D6FD Q40179856-42379709-631F-4013-9874-BB773DD1EF6A Q40781300-83894804-C8FD-461C-A06D-E31B2B274AA3 Q45939546-6CED552A-0816-4646-9EAF-87CCB1A9C73F Q46143417-8547AD98-1800-4DD3-A23F-CF606A2CD9D8 Q47805959-DF2F8767-3AC1-413F-954F-D0F96A20B8F4 Q50422207-CAA76661-F270-4219-A987-52058FF2F86C Q52318200-6F91B543-94AB-4BCC-9BAF-D63A367D1719 Q55163802-6CE72CE2-2E6E-4A36-B272-0CF0098818E5

P2860

Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.

http://www.wikidata.org/entity/Q35430146

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Differences in outcomes of new ...... the Children's Oncology Group.

@ast

Differences in outcomes of new ...... the Children's Oncology Group.

@en

type

label

Differences in outcomes of new ...... the Children's Oncology Group.

@ast

Differences in outcomes of new ...... the Children's Oncology Group.

@en

prefLabel

Differences in outcomes of new ...... the Children's Oncology Group.

@ast

Differences in outcomes of new ...... the Children's Oncology Group.

@en

P1433

Q35430146-960F94B2-3820-45F1-8450-C20A5EE499A8

P1476

Q35430146-DEBCBD72-C0B8-470B-BF2E-9CACF00EE53C

P2093

Q35430146-23C1487A-0884-496F-BB38-65D74881AD62

Q35430146-2857B47C-642A-43DA-9969-0B517834A521

Q35430146-30FB19F8-30E6-4B62-80A6-D19A2A2FE455

Q35430146-428ADD60-E7F5-41ED-A0E3-F139B2987BCC

Q35430146-4381C85E-D274-4FA6-949D-C84EE093E1EC

Q35430146-59CE6702-B952-48FF-88D8-DE966121B3AA

Q35430146-5C499F69-608C-465F-A8FD-5FEE9840AE76

Q35430146-920CD996-CFF1-4468-BDF7-C9788F9E9ED3

Q35430146-A7BBC907-B997-422D-BFB9-D204FBE6AAE6

Q35430146-C6F3C2CB-8015-403F-8A79-F3BFC02D9D27

P2860

Q35430146-0C1A2598-4E7D-4F79-BA8D-9CD8A599E0F2

Q35430146-0D5E764A-DA62-445D-881F-02CB05BE6160

Q35430146-2A6C7D15-9320-445B-AE01-3A6E10E467ED

Q35430146-3C460CA4-675E-4748-A65D-7056565CBBA1

Q35430146-494319C3-4731-42BC-B009-302964416DDE

Q35430146-57643DDC-FDAA-40C2-8F6C-D93E3860DCED

Q35430146-7CA9212A-8985-40C2-907E-5FE8B8742ACF

Q35430146-7D791EB7-D081-4D9B-8E3D-BA3450B34C79

Q35430146-97D1E1BC-B002-445E-8C51-9C9719DBDAA7

Q35430146-A971BED4-D0B9-4117-AB59-18E2F0D0D0E9

P304

Q35430146-2226503E-8F57-451A-8E37-F17F871AA335

P31

Q35430146-2B2BA0E8-2D57-4C6D-9FFF-061A14ECE3BA

P356

Q35430146-E3FA89BB-0371-4798-A46C-681462128277

P407

Q35430146-FB7A037A-BFCE-4B62-82A3-7E5ACBDACFC1

P433

Q35430146-40040CC8-F3A1-48F8-8388-03C753559B35

P478

Q35430146-B4B4DC1F-760D-48BE-A35D-7703E99074A5

P577

Q35430146-82BCA94F-2197-43E0-8B6A-FC57024A7560

P698

Q35430146-A2B560C4-C78A-413E-B7A4-3DA6515BD12A

P921

Q35430146-8F08229C-FEC1-4D6D-93A7-23FEDC694D48

P932

Q35430146-75C4FEB8-4672-4226-AAAB-4CD82923BE26

P356

P1433

P1476

Differences in outcomes of new ...... the Children's Oncology Group.

@en

P2093

Alan Gamis

http://www.w3.org/2001/XMLSchema#string

Beverly J Lange

http://www.w3.org/2001/XMLSchema#string

David R Freyer

http://www.w3.org/2001/XMLSchema#string

Janet Franklin

http://www.w3.org/2001/XMLSchema#string

Jason Canner

http://www.w3.org/2001/XMLSchema#string

John Horan

http://www.w3.org/2001/XMLSchema#string

John Perentesis

http://www.w3.org/2001/XMLSchema#string

Robert B Gerbing

http://www.w3.org/2001/XMLSchema#string

Soheil Meshinchi

http://www.w3.org/2001/XMLSchema#string

Todd A Alonzo

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421.

Clinical pharmacology in the adolescent oncology patient.

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.

Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia.

Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group

Clinical implications of FLT3 mutations in pediatric AML.

The incidence and clinical significance of nucleophosmin mutations in childhood AML.

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.

Children's Oncology Group (COG) Nutrition Committee.

P304

4162-4169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.28342

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24104395

http://www.w3.org/2001/XMLSchema#string

P921

P932

4398142

http://www.w3.org/2001/XMLSchema#string